Delivery Order SPE2DB24D3013-SPE2DB24FFHSK

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,595.34 firm fixed price delivery order covers the supply of Carvedilol ER 40 mg capsules to support military healthcare programs. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,166.97 firm fixed-price delivery order is for the supply of Carvedilol ER 40 mg capsules. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,617.82 firm fixed-price delivery order is for the supply of Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Carvedilol ER 40 mg capsules. The $1,061.36 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support to the U.S. military. The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This federal contract award, valued at $5,063.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Carvedilol ER 40 mg capsules, a medication used to treat heart conditions. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,066.14 firm fixed-price delivery order is for the supply of Carvedilol ER 10 mg capsules, a cardiovascular medication. The contract has a completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,479.45 firm fixed-price delivery order is for the supply of Carvedilol ER 40 mg capsules. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 40 mg capsules. The $10,734.40 firm fixed-price contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,527.20 firm fixed-price delivery order is for the supply of 4,566,963,984 units of Carvedilol ER 40 mg capsules. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,661.35 delivery order contract is for the supply of Carvedilol ER 40 mg capsules, a cardiovascular medication. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFHSK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,599.83 Firm Fixed Price delivery order is for the supply of Carvedilol ER 40 mg capsules. The contract has a completion date of September 11, 2024.

Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a comprehensive range of pharmaceutical and medical products to support military, veterans, and other government healthcare programs nationwide. This specific award does not include any set-aside designations.

Generated 12/10/24, 2:23 PM